nanoparticle vaccine immunotherapy

First-of-its-kind nanoparticle vaccine immunotherapy targets several different cancer types

Researchers from UT Southwestern Medical Center have developed a first-of-its-kind nanoparticle vaccine immunotherapy that targets several